Live feed08:00:00·1436dPRReleaseCytovia Therapeutics to Present In Vivo Multiple Myeloma Data of its CD38-Targeting Flex-NK™ Cell Engager at EHA 2022 CongressISLE· Isleworth Healthcare Acquisition CorporationIndustrialsOriginal source